Evaluation of hypertensive patients after care provided by community pharmacists in a rural setting

Pharmacotherapy

Volumn 17, Issue 6, 1997, Pages 1274-1285

  Carter, Barry L ^a   Barnette, Debra J ^a   Chrischilles, Elizabeth ^b   Mazzotti, Gordon J ^c   Asali, Ziad J ^d  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c Rene's Drug Store Inc   (United States)

^d Christian County Medical Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; AGED; ARTICLE; BLOOD PRESSURE REGULATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DRUG COST; ESSENTIAL HYPERTENSION; FEMALE; HEALTH CARE QUALITY; HUMAN; MALE; PATIENT SATISFACTION; PEER REVIEW; PHARMACEUTICAL CARE; PHARMACIST; PRESCRIPTION; QUALITY OF LIFE; RURAL HEALTH CARE; SINGLE BLIND PROCEDURE; SKILL; STAFF TRAINING; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; COMMUNITY PHARMACY SERVICES; DATA COLLECTION; FEMALE; HUMANS; HYPERTENSION; ILLINOIS; MALE; MIDDLE AGED; PATIENT SATISFACTION; PHARMACISTS; QUALITY OF LIFE; RURAL HEALTH SERVICES; SINGLE-BLIND METHOD; TREATMENT OUTCOME;

EID: 0030693716     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Burt VL, Whelton P, Roccella EJ, et al. Prevalence of hypertension in the US adult population: results from the third National Health and Nutrition Examination Survey, 1988-1991. Hypertension 1995;25:305-13.
2. Christensen DB, Campbell WH, Madsen S, Hartzema AG, Nudelman PM. Documenting outpatient problem intervention activities of pharmacists in an HMO. Med Care 1981;19:104-16.
3. Manasse HR Jr. Medication use in an imperfect world: drug misadventuring as an issue of public policy (part 1). Am J Hosp Pharm 1989;46:929-44.
4. Manasse HR Jr. Medication use in an imperfect world: drug misadventuring as an issue of public policy (part 2). Am J Hosp Pharm 1989;46:1141-52.
5. Solomon DK, Baumgartner RP Jr, Weissman AM, Brisco ME, Smith RM, McCormick WC. Use of medication profiles to detect potential therapeutic problems in ambulatory patients. Am J Hosp Pharm 1974;31:348-54.
6. Carter BL, Helling DK. Ambulatory care pharmacy services: the incomplete agenda. Ann Pharmacother 1992;26:701-8.
7. McKenney JM, Slining JM, Henderson HR, Devins D, Barr M. The effect of clinical pharmacy services on patients with hypertension. Circulation 1973;48:1104-11.
8. Park JJ, Kelly P, Carter BL, Burgess PP. Comprehensive pharmaceutical care in the chain setting. J Am Pharm Assoc 1996;36:443-51.
9. Joint National Committee on the Detection, Evaluation, and Treatment of High Blood Pressure. The fifth report of the Joint National Committee on the Detection, Evaluation, and Treatment of High Blood Pressure (JNC-V). Arch Intern Med 1993;153:154-83.
10. Barnette DJ, Murphy CM, Carter BL. Clinical skill development for community pharmacists. J Am Pharm Assoc 1996;36:573-80.
11. Stewart AL, Hays RD, Ware JE. The MOS short-form general health survey: reliability and validity in a patient population. Med Care 1988;26:724-35.
12. Frohlich ED, Grim C, Labarthe DR, Maxwell MH, Perloff D, Weidman WH. Recommendations for human blood pressure determination by sphygmomanometers: report of a special task force appointed by the steering committee, American Heart Association. Dallas: American Heart Association, 1987.
13. SAS Institute. SAS/STAT user's guide. Release 6.03 ed. Cary, NC: SAS Institute, 1992.
14. Brown DJ, Helling DK, Jones ME. Evaluation of clinical pharmacist consultations in a family practice office. Am J Hosp Pharm 1979;36:912-15.
15. Carter BL, Helling DK, Jones ME, Moessner H, Waterbury CA Jr. Evaluation of family physician prescribing: influence of the clinical pharmacist. Drug Intell Clin Pharm 1984;18:817-21.
16. Chrischilles EA, Helling DK, Aschofff CR. Effect of clinical pharmacy services on the quality of family practice physician prescribing and medication costs. Drug Intell Clin Pharm 1989;23:417-21.
17. Eisen SA, Miller DK, Woodward RS, Spitznagel E, Przybeck TR. The effect of prescribed daily dose frequency on patient medication compliance. Arch Intern Med 1990;150:1881-4.
18. Hawkins DW, Fiedler FP, Douglas HL, Eschbach RC. Evaluation of a clinical pharmacist in caring for hypertensive and diabetic patients. Am J Hosp Pharm 1979;36:1321-5.
19. Morse GD, Douglas JB, Upton JH, Rodgers S, Gal P. Effect of pharmacist intervention on control of resistant hypertension. Am J Hosp Pharm 1986;43:905-9.
20. Monson R, Bond CA, Schuna A. Role of the clinical pharmacist in improving drug therapy: Clinical pharmacists in outpatient therapy. Arch Intern Med 1981;141:1441-4.
21. Bond CA, Monson R. Sustained improvement in drug documentation, compliance, and disease control: a four-year analysis of an ambulatory care model. Arch Intern Med 1984;144:1159-62.
22. Hanlon JT, Weinberger M, Samsa GP, et al. A randomized, controlled trial of a clinical pharmacist intervention to improve inappropriate prescribing in elderly outpatients. Am J Med 1996;100:428-37.
23. Erickson SR, Slaughter R, Halapy H. Pharmacists' ability to influence outcomes of hypertension therapy. Pharmacotherapy 1997;17:140-7.
24. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the systolic hypertension in the elderly program (SHEP). JAMA 1991;265:3255-64.
25. Haxby DG, Weart CW, Goodman BW Jr. Family practice physicians' perceptions of the usefulness of drug therapy recommendations from clinical pharmacists. Am J Hosp Pharm 1988;45:824-7.
26. Helling DK, Hepler CD, Jones ME. Effect of direct clinical pharmaceutical services on patients' perceptions of health care quality. Am J Hosp Pharm 1979;36:325-9.